The H5N1 (bird flu) virus has proven its ability to cause severe infections in humans and experts are now warning …
Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Category:
Drugs
-
-
Asian, Black, and Hispanic patients with commercial insurance spent significantly more on out-of-pocket maternity care than White patients, according to …
-
Community pharmacists participating in a Medicaid Managed Care Organization payer program exhibited significant expertise in addressing the complex health needs …
-
Repurposing amlodipine, a medication commonly used for blood pressure, shows potential as a novel treatment for attention-deficient/hyperactivity disorder (ADHD), according …
-
The FDA approved denosumab-dssb (Ospomyv; previously SB16) and denosumab-dssb (Xbryk; previously SB16) as biosimilars referencing Prolia and Xgeva, respectively. Both …
-
Drugs
Automated Insulin Delivery Significantly Lowered A1c for Patients With T2D
by Newsroomby NewsroomAutomated insulin delivery significantly lowered hemoglobin A1c (HbA1c) levels for patients with type 2 diabetes (T2D), according to data published …
-
The FDA approved chikungunya vaccine, recombinant (Vimkunya), as the first virus-like particle single-dose vaccine against chikungunya for patients 12 years …
-
Subanesthetic doses of esketamine (Spravato) showed improvements in pain and decreased adverse events for patients undergoing elective orthopedic surgery, according …
-
Major payer coverage policies for 11 drugs often met fair access criteria, according to the Institute for Clinical and Economic …
-
The FDA accepted a supplemental biologics license application for dupilumab (Dupixent) for priority review to treat adults with bullous pemphigoid.1 …